Project Grant R01EY035499
Award Date
9/30/24
Completion Date
8/31/28
Dollars Obligated
$974K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
The National Eye Institute (NEI) awarded a $488,639 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Pittsburgh to identify the mechanisms underlying the enhanced virulence of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa that has caused a concerning outbreak of keratitis infections. The funding will support research to systematically test the unique virulence factors of this outbreak strain and develop more effective...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The $425,000 award, effective August 1, 2024 through July 31, 2029, will support the Massachusetts Eye and Ear Infirmary in creating a metagenomic sequencing-based platform that uses portable nanopore sequencers to provide...
The National Eye Institute (NEI) awarded a $813,213 Project Grant (CFDA 93.867 - Vision Research) to the Icahn School of Medicine at Mount Sinai to conduct a multiomic analysis of preclinical biomarkers for primary open-angle glaucoma (POAG). The 5-year research project will analyze proteomic and metabolomic profiles in plasma samples from a matched case-control group nested within prospective health studies, along with genetic and clinical data, to better understand POAG pathophysiology and...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $192,500.00 to Wayne State University to evaluate the impact of acute and chronic opioid exposure on ocular innate immunity and the pathogenesis of infectious endophthalmitis. The research aims to elucidate the mechanisms by which opioid use disorder impairs innate immune responses in retinal and myeloid cells, and determine if opioid use increases susceptibility and severity of...
The National Eye Institute (NEI), through its Vision Research federal grant program (CFDA 93.867), awarded a $247,800 Project Grant to Oregon Health & Science University (OHSU) to develop novel tools to help diagnose and classify uveitis, a common cause of blindness in the United States. The project aims to (1) develop ultrahigh-resolution optical coherence tomography (OCT) for imaging the anterior and vitreous media of the eye, and (2) quantify and classify inflammation in the aqueous and...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will provide $1,083,078.00 to the University of California, Irvine (UC Irvine) over the period of September 30, 2024 to June 30, 2028. The project aims to examine the role of monocytes and neutrophils in fungal keratitis, a leading cause of corneal blindness and vision loss. Key objectives include investigating neutrophil activation and the effect of monocyte depletion on...
The U.S. National Eye Institute (NEI) awarded a $184,117 Project Grant (CFDA 93.867 - Vision Research) to Oakland University to determine the role of G-coupled protein receptors GPR31 and GPR39 in the pathogenesis of diabetic retinopathy. The project aims to investigate the affinities and substrate specificities of GPR31 and GPR39 for 12- and 15-HETE metabolites in retinal endothelial cells and Müller cells under normal and hyperglycemic conditions. It will also examine the effects of GPR31 or...
This Project Grant award of $869,528 from the National Eye Institute (NEI), part of the NIH Vision Research program (CFDA 93.867), aims to develop an Automated Quantitative Ulcer Analysis (AQUA) algorithm and a point-of-care decision tool to rapidly identify the causative organism type in cases of microbial keratitis, a leading cause of worldwide blindness. The project has four key objectives: 1) Identify risk factors associated with organism types, 2) Create and validate a novel machine...
This $201,825 Project Grant award from the National Eye Institute (NEI) Vision Research program (CFDA 93.867) supports research to evaluate the use of condensin inhibitors as a potential topical treatment for Pseudomonas aeruginosa bacterial eye infections. The lead investigator, Dr. Valentin Rybenkov at the University of Oklahoma, will collaborate with Dr. Michelle Callegan at the University of Oklahoma Health Sciences Center to conduct in vivo studies examining the toxicity, corneal...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports a research study to investigate the relationship between the gut microbiota, fecal metabolome, and disease activity in patients with non-infectious uveitis. The total award amount is $286,534 and the performance period is from January 1, 2025 to December 31, 2028. The principal investigator and awardee is the Regents of the University of Michigan, a prominent U.S. state government-owned...